Literature DB >> 2406358

Macrophage-parasite interactions in Leishmania infections.

J Mauël1.   

Abstract

Macrophages have different roles in Leishmania infections. They function as host-cells to the parasite, they present parasite antigens to the immune system, and they also act as effector cells responsible for parasite killing in the healing stages of the infection. Protein and carbohydrate ligands on the parasite surface, which interact with receptors on the macrophage membrane during phagocytosis, have been identified. Survival of Leishmania in its host cell requires a metabolic adaptation to the intracellular environment. The nutritional requirements of the microorganism must be satisfied and the deleterious effect of oxygen metabolites and of lysosomal hydrolases must be adequately counteracted. When a successful immune response develops, macrophages become activated and acquire the capacity to destroy the microorganism. Possible reasons why these mechanisms fail in certain individuals or experimental host-parasite combinations are discussed.

Entities:  

Mesh:

Year:  1990        PMID: 2406358     DOI: 10.1002/jlb.47.2.187

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  19 in total

1.  Biodistribution and In Vivo Antileishmanial Activity of 1,2-Distigmasterylhemisuccinoyl-sn-Glycero-3-Phosphocholine Liposome-Intercalated Amphotericin B.

Authors:  Maryam Iman; Zhaohua Huang; Seyedeh Hoda Alavizadeh; Francis C Szoka; Mahmoud R Jaafari
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

2.  Transgenic expression of CXCR3 on T cells enhances susceptibility to cutaneous Leishmania major infection by inhibiting monocyte maturation and promoting a Th2 response.

Authors:  Steve Oghumu; James C Stock; Sanjay Varikuti; Ran Dong; Cesar Terrazas; Jessica A Edwards; Chad A Rappleye; Ariel Holovatyk; Arlene Sharpe; Abhay R Satoskar
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

3.  Live nonpathogenic parasitic vector as a candidate vaccine against visceral leishmaniasis.

Authors:  Marie Breton; Michel J Tremblay; Marc Ouellette; Barbara Papadopoulou
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene.

Authors:  H Charest; G Matlashewski
Journal:  Mol Cell Biol       Date:  1994-05       Impact factor: 4.272

5.  Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice.

Authors:  Mahmoud R Jaafari; Neda Bavarsad; Bibi Sedigheh Fazly Bazzaz; Afshin Samiei; Dina Soroush; Serajodin Ghorbani; Mohammad M Lotfi Heravi; Ali Khamesipour
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

6.  Multicellular oxidant defense in unicellular organisms.

Authors:  M Ma; J W Eaton
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-01       Impact factor: 11.205

7.  Granulocyte-macrophage colony-stimulating factor increases the infectivity of Leishmania amazonensis by protecting promastigotes from heat-induced death.

Authors:  M A Barcinski; D Schechtman; L G Quintao; D de A Costa; L R Soares; M E Moreira; R Charlab
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

8.  Natural and acquired resistance to Leishmania: cellular activation by Leishmania aethiopica of mononuclear cells from unexposed individuals is through the stimulation of natural killer (NK) cells.

Authors:  H Akuffo; K Maasho; R Howe
Journal:  Clin Exp Immunol       Date:  1993-12       Impact factor: 4.330

9.  Antileishmanial Activity of Liposomal Clarithromycin against Leishmania Major Promastigotes.

Authors:  Ameneh Sazgarnia; Naghmeh Zabolinejad; Pouran Layegh; Omid Rajabi; Fariba Berenji; Zari Javidi; Roshanak Salari
Journal:  Iran J Basic Med Sci       Date:  2012-11       Impact factor: 2.699

10.  Targeting Leishmania major Antigens to Dendritic Cells In Vivo Induces Protective Immunity.

Authors:  Ines Matos; Olga Mizenina; Ashira Lubkin; Ralph M Steinman; Juliana Idoyaga
Journal:  PLoS One       Date:  2013-06-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.